Clinical Trial Update: Neoadjuvant RCT Versus CT for Patients With Locally Advanced, Potentially Resectable Adenocarcinoma of the GEJ [Phase 3]

View source ↗

Summary

Phase 3 randomized trial update comparing neoadjuvant treatment strategies for locally advanced, potentially resectable gastroesophageal junction adenocarcinoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Junction Adenocarcinoma

Snippet

Sponsor: Universitätsmedizin Mannheim | Conditions: Gastroesophageal Junction Adenocarcinoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING